Asahi Kasei Pharma America Corp.
Division of Asahi Kasei Corp.
www.artisanpharma.net
Latest From Asahi Kasei Pharma America Corp.
Asahi Kasei aims for global market through Phase III trials with novel anticoagulant
The diversified Japanese materials group Asahi Kasei is planning to take its recombinant human thrombomodulin-alfa product ART-123 into the global arena through the start of an international Phase III trial for the treatment of severe sepsis and coagulopathy.
Device/Diagnostics Quarterly Deal Statistics, Q1 2012
Medical device companies raised $1.1 billion, a 40% increase over Q4 2011’s $800 million. Two billion-dollar deals in the resuscitation market boosted device acquisition activity to $4.2 billion. Twenty diagnostics financings brought in a collective $302 million, soaring above the previous quarter’s $269 million. There were seven diagnostics M&A deals completed, totaling $589 million – down yet again.
Deals Shaping The Medical Industry (12/2011)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Japan’s AKP Takes Over Artisan To Progress ART-123
Japan's Asahi Kasei Pharma announced Nov. 22 that its acquisition of Massachusetts-based Artisan Pharma, a company it spun out in 2006.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Blood & Coagulation Disorders & Products
- Alias(es)
- Artisan Pharma Inc.
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Asahi Kasei Corp.
- Senior Management
-
Naoyuki Ono, Chmn. & CEO
Inder Kaul, MD, CMO
John Charest, Sr. Dir., Fin.
Kazuhisa Tsuruta, SVP, CSO - Contact Info
-
Asahi Kasei Pharma America Corp.
Phone: (781) 419-1919
230 Third Ave.
Waltham, MA 02451
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice